WT1 and neoplasm: The Combined HAGE/WT1 ImmunoBody® Vaccine Provokes In Vivo Anti-Tumour Effector T Cell Function in HHDII/DR1 Mice Bearing hB16/HAGE+/Luc+ Tumour